These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8335981)

  • 1. Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans.
    Torosantucci A; Bromuro C; Gomez MJ; Ausiello CM; Urbani F; Cassone A
    J Infect Dis; 1993 Aug; 168(2):427-35. PubMed ID: 8335981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans.
    Torosantucci A; Palma C; Boccanera M; Ausiello CM; Spagnoli GC; Cassone A
    J Gen Microbiol; 1990 Nov; 136(11):2155-63. PubMed ID: 1706757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans.
    Ausiello CM; Urbani F; Gessani S; Spagnoli GC; Gomez MJ; Cassone A
    Infect Immun; 1993 Oct; 61(10):4105-11. PubMed ID: 8406799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.
    Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A
    Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.
    Gomez MJ; Torosantucci A; Arancia S; Maras B; Parisi L; Cassone A
    Infect Immun; 1996 Jul; 64(7):2577-84. PubMed ID: 8698482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and antigenic characterization of mannoprotein constituents released from yeast and mycelial forms of Candida albicans.
    Torosantucci A; Gomez MJ; Bromuro C; Casalinuovo I; Cassone A
    J Med Vet Mycol; 1991; 29(6):361-72. PubMed ID: 1815028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans.
    Bromuro C; Torosantucci A; Gomez MJ; Urbani F; Cassone A
    J Med Vet Mycol; 1994 Dec; 32(6):447-59. PubMed ID: 7738727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones.
    Nisini R; Romagnoli G; Gomez MJ; La Valle R; Torosantucci A; Mariotti S; Teloni R; Cassone A
    Infect Immun; 2001 Jun; 69(6):3728-36. PubMed ID: 11349037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannoproteins from Candida albicans elicit a Th-type-1 cytokine profile in human Candida specific long-term T cell cultures.
    La Sala A; Urbani F; Torosantucci A; Cassone A; Ausiello CM
    J Biol Regul Homeost Agents; 1996; 10(1):8-12. PubMed ID: 9049775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of human polymorphonuclear cells (PMNL) to stimulation by a mannoprotein fraction (MP-F2) of Candida albicans; enhanced production of IL-6 and tumour necrosis factor-alpha (TNF-alpha) by MP-F2-stimulated PMNL from HIV-infected subjects.
    Torosantucci A; Chiani P; Quinti I; Ausiello CM; Mezzaroma I; Cassone A
    Clin Exp Immunol; 1997 Mar; 107(3):451-7. PubMed ID: 9067516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.
    Gomez MJ; Maras B; Barca A; La Valle R; Barra D; Cassone A
    Infect Immun; 2000 Feb; 68(2):694-701. PubMed ID: 10639435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans.
    La Valle R; Sandini S; Gomez MJ; Mondello F; Romagnoli G; Nisini R; Cassone A
    Infect Immun; 2000 Dec; 68(12):6777-84. PubMed ID: 11083795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans.
    Levitz SM; North EA
    J Med Vet Mycol; 1997; 35(4):229-36. PubMed ID: 9292418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mannoprotein constituent of Candida albicans cooperates with antigen in the induction of a specific primary antibody response in cultures of human lymphocytes.
    Luzzati AL; Giacomini E; Torosantucci A; Giordani L; Cassone A
    J Biol Regul Homeost Agents; 1990; 4(4):142-9. PubMed ID: 2096599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antibody forming cells with specificity for Candida albicans mannoproteins in cultures of human peripheral blood lymphocytes.
    Giacomini E; Boccanera M; Giordani L; Cassone A; Luzzati AL
    J Immunol Methods; 1993 Sep; 164(2):203-11. PubMed ID: 7690375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall.
    Vecchiarelli A; Puliti M; Torosantucci A; Cassone A; Bistoni F
    Cell Immunol; 1991 Apr; 134(1):65-76. PubMed ID: 1672836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans.
    Farahnejad Z; Rasaee MJ; Moghadam MF; Paknejad M; Kashanian S; Rajabi M
    Hybridoma (Larchmt); 2005 Jun; 24(3):146-51. PubMed ID: 15943562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low responsiveness to Candida antigens in kidney transplant recipients.
    Ausiello CM; Spagnoli GC; Sconocchia G; Pisani F; Adorno D; Casciani CU
    Microbiologica; 1991 Oct; 14(4):325-32. PubMed ID: 1775088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism.
    Smeekens SP; Gresnigt MS; Becker KL; Cheng SC; Netea SA; Jacobs L; Jansen T; van de Veerdonk FL; Williams DL; Joosten LA; Dinarello CA; Netea MG
    Cytokine; 2015 Feb; 71(2):215-22. PubMed ID: 25461401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.